Skip to search.
 TSX Up 0.54% TSX Ventures Up 0.56%

Incyte Corporation (INCY)

-NasdaqGS
104.08 Up 3.26(3.23%) 3:50PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:100.82
Open:103.01
Bid:103.89 x 100
Ask:103.98 x 200
1y Target Est:118.09
Beta:-0.2
Earnings Date:Aug 3 - Aug 7 (Est.)
Day's Range:101.71 - 104.34
52wk Range:43.86 - 113.55
Volume:956,093
Avg Vol (3m):1,068,310
Market Cap:18.63B
P/E (ttm):N/A
EPS (ttm):-0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
INCYUp 3.23%18.63B
AMGNUp 1.42%116.91B
CELGUp 0.91%91.97B
RHHBYDown 1.08%N/A

Key Statistics

Forward P/E (1 yr):118.11
P/S (ttm):31.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.27
Quarterly EPS Est (Jun-15) :-0.11
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-5.51

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback